This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Herb Greenberg

Editor, Herb Greenberg's Reality Check

Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk. He writes a daily blog for TheStreet's main free Web site and contributes to its Real Money's "Columnist Conversation" column as well as being a regular contributor for CNBC.

Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's business day programming and on He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MarketWatch.

Prior to joining MarketWatch, Greenberg was senior columnist for TheStreet. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years as Fortune magazine's monthly "Against the Grain" columnist. Before that, he was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.

Greenberg holds a bachelor's degree in journalism from the University of Miami.

Herb Greenberg
By This Author:
« Back
Page 1 of 473

Greenberg: Where are the Cops?

By Herb Greenberg

The halt in CYNK Technology points up the inaction on Lumber Liquidators and the heavy put options trading on other stocks.

12:25PM 07/11/14

Greenberg: No Surprise in Potbelly's Flop

By Herb Greenberg

Potbelly was one of those disasters you could see coming. Ever since its IPO, its stock has done little more than head lower, and for good reason.

06:24PM 07/09/14

Greenberg: What Ails the Container Store?

By Herb Greenberg

The Container Store is finding out that a publicly traded retailer has to balance investors' needs with protection of the company's special character.

12:55PM 07/09/14


What Ails The Container Store? (Reality Check $)

By Herb Greenberg

Whenever a retailer with a good concept goes public, the challenge is to balance the need to feed The Street with protecting what made it so special.

11:57AM 07/09/14

Greenberg: Maybe It Wasn't the Weather, After All?

By Herb Greenberg

In the recent quarter or two, companies -- especially retailers -- blamed the weather for dismal performance. But on Tuesday, retailers had to blame something else.

06:40PM 07/08/14

Greenberg: A Reminder That Fraud Is Alive and Well

By Herb Greenberg

It's rare that a company confesses to creating a fiction, but that's exactly what has happened in recent days in the bizarre tale of Let's Gowex.

01:39PM 07/07/14


Update: Can Tibco Hold Activists at Bay? (Reality Check $)

By Herb Greenberg

Investors are lukewarm to its latest moves, but the company could easily be sold.

11:11AM 06/20/14


Update: Shifting Stericycle to Red Flag (Reality Check $)

By Herb Greenberg

Its broader legal issues coincide with a slowdown in growth.

06:57AM 06/20/14

Greenberg: CBI's 'The Shorts are Conflicted' Strategy

By Herb Greenberg

Disclosure: I've done zero work, and have no intentions to do any work, on Chicago Bridge & Iron CBI, which was the focus of an accounting takedown by Prescience Point Research Group.But I do have a take on CBI's response -- and I wouldn't be saying anything if it wasn't for the nature of its response.Not this part:CB&I has reviewed the report and strongly disagrees with its assumptions and conclusions.But this part:Notably, the report warns readers to assume that the short-selling firm and/or its affiliates hold short positions in CB&I common stock and that they stand to realize significant gains in the event that CB&I's stock price declines. CB&I believes that this conflict of interest should cause the report and its conclusions to be viewed skeptically.To which I say: Of course they're conflicted -- but no more or less conflicted than somebody own owns the stock. Prescience Point, which says it spoke with the company twice during its research, discloses that it's short at the top of its report.This ridiculous concept of trying to deflect critical commentary because the author is short is feeble, amateurish and, well, absurd, unless the company also criticizes bullish reports by analysts who it believes are conflicted because they own the stock.Reality: Everybody, if they own or short a stock, is conflicted. Everybody talks their book. That's Wall Street.

02:01PM 06/18/14

Greenberg: The Tesla-izing of SolarCity?

By Herb Greenberg

If all else fails, or at least the stock isn't sizzling the way it should be, change the story. That's the moral of SolarCity, with news that it's planning to acquire Silevo, an unknown maker of high-efficient solar panels. The deal, in SolarCity's words, will make it the "most vertically integrated solar company in the world." We can slice it and dice it any way we want, but to Reality Check the most striking part of the the deal was the role Elon Musk, SolarCity's chairman: He opened the call and pretty much ended it. Until now, he has has been much more of a silent partner at a company run by his cousins, Lyndon and Peter Rive. The obvious question: Why do this deal?

05:31PM 06/17/14

« Back
Page 1 of 473

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs